Screening for prostate cancer - The challenge of promoting informed decision making in the absence of definitive evidence of effectiveness

被引:26
作者
Burack, RC
Wood, DP
机构
[1] Wayne State Univ, Sch Med, Dept Surg, Detroit, MI 48201 USA
[2] Wayne State Univ, Sch Med, Urol Sect, Detroit, MI 48201 USA
[3] Wayne State Univ, Sch Med, Sect Urol Oncol, Detroit, MI 48201 USA
[4] Barbara Ann Karmanos Canc Inst, Detroit, MI USA
[5] Wayne State Univ, Sch Med, Dept Internal Med, Detroit, MI 48201 USA
关键词
D O I
10.1016/S0025-7125(05)70173-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Evidence demonstrating the burden of prostate cancer upon men in the United States is incontrovertible; less compelling however, is proof of benefit from early detection efforts. Nevertheless, the absence of definitive evidence does not lessen the interest of men in prostate testing or the obligation of physicians to help interested men make well-informed decisions, which integrate personal circumstance and preference with the best available data. This article provides the counseling physician with the information required to frame the current prostate testing debate and an approach to support informed decision making by men who can benefit from their assistance.
引用
收藏
页码:1423 / +
页数:21
相关论文
共 65 条
[1]   Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer [J].
Albertsen, PC ;
Hanley, JA ;
Gleason, DF ;
Barry, MJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (11) :975-980
[2]  
*AM CANC SOC, 1998, SUMM AM CANC SOC REC
[3]  
[Anonymous], EX COMM REP
[4]   LONG-TERM SURVIVAL AND MORTALITY IN PROSTATE-CANCER TREATED WITH NONCURATIVE INTENT [J].
AUS, G ;
HUGOSSON, J ;
NORLEN, L .
JOURNAL OF UROLOGY, 1995, 154 (02) :460-465
[5]   Determinants of prostate-specific antigen test use in prostate cancer screening by primary care physicians [J].
Austin, OJ ;
Valente, S ;
Hasse, LA ;
Kues, JR .
ARCHIVES OF FAMILY MEDICINE, 1997, 6 (05) :453-458
[6]   A CRITIQUE OF THE DECISION-ANALYSIS FOR CLINICALLY LOCALIZED PROSTATE-CANCER [J].
BECK, JR ;
KATTAN, MW ;
MILES, BJ .
JOURNAL OF UROLOGY, 1994, 152 (05) :1894-1899
[7]   Biological aggressiveness of hereditary prostate cancer: Long-term evaluation following radical prostatectomy [J].
Bova, GS ;
Partin, AW ;
Isaacs, SD ;
Carter, BS ;
Beaty, TL ;
Isaacs, WB ;
Walsh, PC .
JOURNAL OF UROLOGY, 1998, 160 (03) :660-663
[8]   SELECTION OF OPTIMAL PROSTATE-SPECIFIC ANTIGEN CUTOFFS FOR EARLY DETECTION OF PROSTATE-CANCER - RECEIVER OPERATING CHARACTERISTIC CURVES [J].
CATALONA, WJ ;
HUDSON, MA ;
SCARDINO, PT ;
RICHIE, JP ;
AHMANN, FR ;
FLANIGAN, RC ;
DEKERNION, JB ;
RATLIFF, TL ;
KAVOUSSI, LR ;
DALKIN, BL ;
WATERS, WB ;
MACFARLANE, MT ;
SOUTHWICK, PC .
JOURNAL OF UROLOGY, 1994, 152 (06) :2037-2042
[9]   Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination - Enhancement of specificity with free PSA measurements [J].
Catalona, WJ ;
Smith, DS ;
Ornstein, DK .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (18) :1452-1455
[10]   SHOULD MEDICARE PROVIDE REIMBURSEMENT FOR PROSTATE-SPECIFIC ANTIGEN TESTING FOR EARLY DETECTION OF PROSTATE-CANCER .2. EARLY DETECTION STRATEGIES [J].
COLEY, CM ;
BARRY, MJ ;
FLEMING, C ;
WASSON, JH ;
FAHS, MC ;
OESTERLING, JE .
UROLOGY, 1995, 46 (02) :125-141